FDA approves opioid-free pain medication with ‘no sign of addiction’
An uneven analgesics without new opioids were approved by the US Food and Drug Administration (FDA) on Thursday, marking non -member alternatives for patients. According to a press release of a Massachusetts -based company, JOURNAVX (SUZETRIGINE), which was created at the top, is a “unable to be approved in the first unrecognized oral pain signal […]
Louisiana escalates battle against medication abortion
Click more news from the hill {beacon} health care health care Big story Louisiana escalates the battle with medication abortions New York doctors were prosecuted on Friday by a large JU in Louisiana, which was intentionally prescribed and provided. During medication It violates the state ban. © THE HILL, GREG NASH It is the […]
New York doctor indicted for allegedly prescribing abortion medication via telemedicine
New York female doctors are charged with allegedly prescribed abortions via remote medicine in Louisiana. Dr. Margaret Carpenter was charged with Louisiana on Friday to be allegedly used remote medicine to prescribe abortions. According to AP communication, carpenter, her company, and colleagues were charged with a criminal abortion of felony using drugs that induce abortion. […]
FDA approves new type of non-opioid pain medication
US Food and Drug Administration (FDA) Approved JOURNAVX (Suzetrigine) oral tablets are the first non -opioid analgesic in class to treat adult acute pain on Thursday. “Today's approval is an important public health milestone in acute pain management,” said Jacqueline Korigan Snowfish, a deputy director of the FDA drug evaluation research center. “The new non […]
FDA approves first medication for obstructive sleep apnea — which also promotes weight loss
The first treatment for obstructive sleep apnea has been approved by the U.S. Food and Drug Administration (FDA). On December 20, the FDA announced that it has approved Eli Lilly's Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea (OSA) in obese adults. The FDA noted that the drug should be combined […]
FDA approves first medication for obstructive sleep apnea, promotes weight loss
The first treatment for obstructive sleep apnea has been approved by the U.S. Food and Drug Administration (FDA). On December 20, the FDA announced that it has approved Eli Lilly's Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea (OSA) in obese adults. The FDA noted that the drug should be combined […]
Costco-brand cold and flu medication recalled by FDA: Here’s what to know
Thousands of Costco-branded cold and flu medicines have been pulled from shelves. A total of 8,640 boxes of Kirkland Severe Cold and Flu Plus Crowded Daypacks and Nightpacks were recalled by the Food and Drug Administration (FDA) last week. This follows the FDA's proposal in early November to ban the use of oral phenylephrine as […]
New medication for ALS eligible for fast-track FDA approval
Researchers say new hope could be on the horizon for ALS patients in the form of a “groundbreaking” drug. Nuvivo, a California biopharmaceutical company developing treatments for neurodegenerative diseases, is seeking approval for a new drug for amyotrophic lateral sclerosis (ALS). According to the ALS Association, ALS is a progressive neurodegenerative disease that gradually impairs […]
Aging slowdown could be surprise benefit of existing medication, research shows
Join Fox News for access to this content Plus, your account will give you exclusive access to select articles and other premium content for free. Enter your email address[続行]By pressing , you agree to Fox News' Terms of Use and Privacy Policy, including notice of financial incentives. Please enter a valid email address. Need help? […]
FDA approves new class of medication for schizophrenia patients
A new drug has been approved to treat schizophrenia in adults. On Thursday, the U.S. Food and Drug Administration (FDA) approved COBENFY (xanomeline and trospium chloride), an oral drug manufactured by Bristol-Myers Squibb of New Jersey. According to a press release, this is the first new class of treatment for brain disorders in decades. 5 […]